epilepsy

Frontiers in Pharmacology | Neuropharmacology section | New and Recent Articles

Dravet syndrome (DS), caused by loss-of-function variants in SCN1A, is classically aggravated by chronic sodium-channel blocker treatment, reflecting impaired interneuron excitability as a core disease mechanism. Cenobamate (CNB) challenges this: adult DS cases with substantial seizure reduction have been reported, while pediatric experience is mixed and includes a small cohort with no responders…

epilepsymedicinepediatricpharmacology
Frontiers in Neuroscience | New and Recent Articles

BackgroundComplex febrile seizures (CFS) confer an elevated risk of epilepsy progression; however, the underlying genetic architecture remains insufficiently characterized in Chinese pediatric populations. This study aimed to delineate the mutational landscape and genotype–phenotype associations in a clinically stratified high-risk febrile seizure cohort.MethodsThis retrospective, single-center s…

biologyepilepsygeneticsmedicinepediatrics
Frontiers in Pharmacology | New and Recent Articles

Cenobamate (CNB) demonstrates high efficacy in drug-resistant focal epilepsy, yet optimal management requires personalized strategies. This exploratory case series describes five patients selected from a cohort of 125 individuals treated with CNB, examining the relationship between pharmacogenetic (PGx) profiles and clinical outcomes. Clinical data and therapeutic drug monitoring (TDM) were integ…

epilepsymedicinepharmacologytherapeutic-drug-monitoring
Frontiers in Psychiatry | New and Recent Articles

IntroductionCerebral cavernous malformations (CCMs) are vascular lesions that can cause focal epilepsy due to local hemosiderin deposition, gliosis, and cortical irritation. Epileptic seizures attributable to CCMs contribute significantly to morbidity and often require long-term management with antiseizure medications (ASMs), but the psychiatric side effect profiles of ASMs remain underreported i…

epilepsymedicationsmedicinepsychiatry
The Medical News
Nature Communications

Nature Communications, Published online: 25 May 2026; doi:10.1038/s41467-026-73053-9 In drug-resistant temporal lobe epilepsy, thalamo–cortical synchrony in the first 20 seconds after seizure onset is stronger in clinical than electrographic seizures, highlighting network engagement as a key driver of seizure symptoms.

clinical-neuroscienceepilepsymedicineneuroscience
Scientific Reports
News Center

A new Northwestern study suggests that interventions for epilepsy can start during pregnancy, as early as 15 weeks gestation, well before symptoms appear, according to a study published in Nature Communications. The post Treatment of Rare Childhood Epilepsy Could Begin Before Birth appeared first on News Center .

epilepsymedicineneurologypediatrics
Frontiers in Human Neuroscience | Brain Health and Clinical Neuroscience section | New and Recent Articles

The SCN8A gene encodes the voltage-gated sodium channel NaV1.6, which is essential for neuronal excitability and action potential propagation. SCN8A variants are associated with a broad clinical spectrum, ranging from self-limiting syndromes to developmental and epileptic encephalopathies. Here, we identified a novel de novo heterozygous SCN8A variant (c.791 T > C/p.Val264Ala) in a 19-year-old fe…

biologyepilepsygeneticsmedicineneurology
The Medical News
Focused Ultrasound Foundation

Charlottesville, VA, and Chicago, IL — April 28, 2026 — The Focused Ultrasound Foundation and CURE Epilepsy have announced the co-funding of an innovative CURE Epilepsy Catalyst Award research grant that may pave the way for better control of debilitating seizures in children. The project aims to develop a noninvasive treatment for a severe form ...

clinical-trialsepilepsymedicineneurology
Newswise: Latest News
Frontiers in Neuroscience | New and Recent Articles

BackgroundDravet syndrome (DS) is a severe developmental and epileptic encephalopathy, mainly caused by SCN1A gene mutations. Its core characteristics are heat sensitivity and refractoriness, and immunoinflammatory factors can participate in the occurrence and development of the disease. At present, the regulatory role of immune inflammation activation in DS has been confirmed, but the specific m…

epilepsyimmunologymedicineneuroimagingneuroscience
Gene Therapy Net - News, Conferences, Vectors, Literature, Clinical Trials and more
info@genetherapynet.com (Administrator)
4/13/2026

Posted on: 13 April 2026, source: National Today A groundbreaking gene regulation treatment developed by Dr. Linda Laux at Ann & Robert H. Lurie Children's Hospital of Chicago has demonstrated significant reductions in seizures and improvements in developmental and cognitive symptoms for patients with Dravet syndrome, a severe form of epilepsy. The treatment targets the root cause of the conditio…

epilepsygene-therapymedicineneurology
Frontiers in Neurology | Neurogenetics section | New and Recent Articles

BackgroundLAMA2-related congenital muscular dystrophy (LAMA2-MD) is a genetically heterogeneous disorder defined by progressive muscle weakness, brain structural abnormalities, epilepsy, and multisystem involvement. The primary goal of this study was to characterize the clinical features, temporal progression, and genotype-phenotype correlations of LAMA2-MD.MethodsMedical records of patients with…

epilepsygeneticsmedicineneurology
Frontiers in Neurology | Neurogenetics section | New and Recent Articles

BackgroundThe CHD2 gene is one of the most common causative genes of developmental and epileptic encephalopathy (DEE). With the advent of high-throughput sequencing, identifying CHD2 variants has increased, necessitating evaluation of the gene-specific performance of widely used tools, as genome-wide benchmarks may mask such heterogeneity.MethodsThe dataset of pathogenic and control CHD2 missense…

epilepsygeneticsmedicineneurology
VIB Blog's pressreleases
India Jane Wise
8/13/2025

Meet Sarah Weckhuysen Sarah Weckhuysen joins the VIB-UAntwerp Center for Molecular Neurology as group leader Prof. Sarah Weckhuysen is a neurologist specialized in epilepsy, with neurology training from KU Leuven and a PhD in Medical Sciences from the University of Antwerp. She has gained extensive experience working in leading epilepsy centers across Spain, the Netherlands, and France. Between 2…

biologyepilepsymedicineneurology
News Center

Investigators in the laboratory of Gemma Carvill, PhD, have discovered novel molecular underpinnings of Dravet syndrome, a rare genetic form of epilepsy in children, that may serve as promising therapeutic targets, according to a recent study. The post Uncovering New Therapeutic Targets for Pediatric Epilepsy appeared first on News Center .

epilepsymedicinepediatric
Juniper Publishers

Neurology & Neurosurgery - Juniper Publishers Abstract Objectives: Recent studies reported that tumor histopathology plays a significant role in predicting freedom from seizures after epilepsy surgery; however, no consensus among researchers regarding this issue exists. This study retrospectively examined different types of tumor-related epilepsy and post-epilepsy surgical outcomes and the r…

epilepsymedicineneurologysurgery
News Center

Using MRI, EEG and clinical characteristics, the pre-surgical workup can predict if patients with epilepsy will benefit from a more invasive examination. The post Improving Pre-Surgical Workups for Epilepsy appeared first on News Center .

diagnosticsepilepsymedicine
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?